Skip to content

Drug interactions

Erdafitinib + Lapatinib

Severity: Moderate

Erdafitinib and Lapatinib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Erdafitinib inhibits P-glycoprotein, a transporter that handles lapatinib, so lapatinib exposure may rise. Higher lapatinib levels can increase diarrhea, hepatotoxicity and QT prolongation.

What this interaction means in plain words

Erdafitinib and Lapatinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Erdafitinib belongs to Oncology; Lapatinib belongs to Oncology.

Evidence level: Low

Why it happens

P-glycoprotein inhibition by erdafitinib increases lapatinib absorption and reduces its efflux.

What to do

If both are needed, give lapatinib at least 6 hours before or after erdafitinib. Monitor for lapatinib adverse effects, liver tests and ECG.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Erdafitinib and Lapatinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Erdafitinib with Lapatinib?

MediHelp rates the interaction as moderate. Erdafitinib and Lapatinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Erdafitinib inhibits P-glycoprotein, a transporter that handles lapatinib, so lapatinib exposure may rise. Higher lapatinib levels can increase diarrhea, hepatotoxicity and QT prolongation.

How serious is the interaction between Erdafitinib and Lapatinib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: If both are needed, give lapatinib at least 6 hours before or after erdafitinib. Monitor for lapatinib adverse effects, liver tests and ECG.

What other medicines interact with Lapatinib?

MediHelp also lists interactions of Lapatinib with, for example, Dofetilide, Ibutilide, Pimozide. The full list is on the Lapatinib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in